Randomized Study of Two Doses of Oral Valacyclovir in Immunocompromised Patients With Uncomplicated Herpes Zoster

NCT00006131 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

66

Enrollment

NIH

Sponsor class

Conditions

Herpes Zoster
Immunologic Deficiency Syndromes

Interventions

DRUG: Valacyclovir

Sponsor

National Center for Research Resources (NCRR)

Collaborators

[object Object]